Don't miss out on your chance to comment! Health care expert Fred Goldstein sits down with Ellen Whipple, BS Pharm, PharmD, to discuss the AMCP Format revision focused on digital therapeutics, health disparities, real-world evidence, PIE Deck guidance, and streamlining dossier development.

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Melissa Andel, Principal and Founder of CommonHealth Solutions to take a closer look at the recent action on Capitol Hill surrounding pharmacy benefit manager reform.

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Melissa Andel, Principal and Founder of CommonHealth Solutions to take a closer look at the recent CMS guidance on drug price negotiation for 2026.

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Melissa Andel, Principal and Founder of CommonHealth Solutions to take a closer look at the recent CMS guidance on drug price negotiation for 2026.

Health care expert Fred Goldstein sits down with Melissa Andel, principal and founder of CommonHealth Solutions, to discuss the long-awaited launch of Humira biosimilars and what Amgen’s pricing strategy means for patients and payers.

2023 will be a pivotal year for biosimilar success or failure. Health care expert Fred Goldstein sits down with Stanton Mehr of Biosimilars Review & Report, to discuss what lies in store for biosimilars and AMCP’s biosimilar initiatives this year.

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Jennifer Graff, Senior Director of Professional Affairs at AMCP, to discuss trends to be watching regarding digital therapeutics and managed care pharmacy in 2023.

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up!, sits down with Susan Cantrell, AMCP CEO, to discuss the significance of the recent passage of the Pre-approval Information Exchange (PIE) Act of 2022.

Andrey Ostrovsky, MD, FAAP, and Lisa Palko, PharmD, discuss the ADHD landscape, challenges, and progress, including Akili's digital therapeutics value proposition as the first FDA-authorized prescription video game treatment.

On today's episode of PopHealth Week, our guest is Eddie Martucci, PhD, co-founder & CEO of Akili Interactive, a company getting to the root of cognitive impairment by creating personalized digital therapeutics engineered to directly improve cognitive impairments.